Navigation Links
Top Scientists to Receive Prestigious Awards From the American Society of Hematology
Date:12/5/2007

ATLANTA, Dec. 5 /PRNewswire-USNewswire/ -- The American Society of Hematology (ASH), the world's largest professional society of blood specialists, is honoring three scientists who have made notable contributions to the genetic understanding of disease. Carlo Croce, MD, will receive the Henry M. Stratton Medal, intended to honor an individual with a distinguished career in hematology, and William P. Vainchenker, MD, PhD, will receive the William Dameshek Prize, awarded to an individual who has made a recent and outstanding contribution to the field. In addition, Ernest Beutler, MD, will be the first recipient of the new Wallace H. Coulter Award for Lifetime Achievement in Hematology, bestowed on an individual who has made a lifelong commitment to the specialty, and whose contributions have had a significant impact on education, research, and/or practice. These awards, named after important figures in the Society's history, will be awarded during the 49th ASH Annual Meeting in December at the Georgia World Congress Center in Atlanta.

"The discoveries made by Drs. Croce, Vainchenker, and Beutler have altered the paradigm of medical thinking not only in hematology, but many other fields as well, and impacted the lives of many patients for the better," said ASH President Andrew Schafer, MD, of the New York Presbyterian-Weill Cornell Medical Center. "It is my honor to recognize these outstanding individuals for their achievements."

With his discovery of the workings of the MYC oncogene in Burkitt lymphoma, Dr. Croce was one of the first to make a case for the genetic basis of cancer. A prolific researcher, he later identified several other genes and their mechanisms of action responsible for the pathogenesis of lymphoma, leukemia, and many other cancers. Dr. Croce is currently Professor and Chairman of the Department of Molecular Virology, Immunology, and Medical Genetics and Director of the Human Cancer Genetics Program at The Ohio State University School of Medicine in Columbus.

Dr. Vainchenker will be recognized for his research on the genetic basis of myeloproliferative diseases, which result in an overproduction of blood cells in the bone marrow. He was the first to find that a single mutation of the JAK2 gene commonly occurred in patients with three distinct disorders: polycythemia vera, idiopathic myelofibrosis, and essential thrombocythemia, a discovery which has profound implications for potential therapies. Dr. Vainchenker is currently INSERM Directeur de Recherche Exceptionnel and Director of the INSERM Unit 790 at the Institut Gustave Roussy in Villejuif, France.

Dr. Beutler is a physician-scientist whose career has spanned more than half a century. Among his many accomplishments, Dr. Beutler made significant contributions to the understanding of the biochemical and genetic causes underlying disorders of the red blood cell, originated the concept of X-chromosome inactivation in human females independently of mouse geneticist Mary Lyon, and provided the first formal proof of this phenomenon - an insight that has become one of the cornerstones of mammalian genetics. He also developed screening tests for the genetic disorders galactosemia and Gaucher disease. He is currently Professor and Chairman, Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA.

Dr. Beutler's award will be presented prior to the Plenary Scientific Session on Sunday, December 9, at 1:30 p.m. EST in Hall A1. Drs. Croce and Vainchenker will be presented with their awards at the Presidential Symposium to be held on Tuesday, December 11, from 9:30 a.m. to 12:00 p.m. in Hall A1. For the complete annual meeting schedule and additional information, please visit http://www.hematology.org/meetings/2007.

The American Society of Hematology (http://www.hematology.org) is the world's largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology.


'/>"/>
SOURCE American Society of Hematology
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
2. Scientists Probe Sepsis Deadly Secrets
3. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
4. Scientists Develop Natural Protection for Stored Foods
5. Scientists detect presence of marburg virus in african fruit bats
6. Scientists Spot Brains Free Will Center
7. Scientists ID Likely Culprit in Popcorn Lung
8. Scientists explain how insulin secreting cells maintain their glucose sensitivity
9. Scripps Research scientists shed new light on how antibodies fight HIV
10. Scientists, physicians present latest findings in personalized cancer treatment and prevention
11. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice ... "Film editors can give their videos a whole new perspective by using the ... of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets to ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... to 2022" report to their offering. ... financial data derived from varied research sources to present unique ... on the market during the next five years, including a ... markets, regional and country level analysis. The report provides a ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 /PRNewswire/ ... Diabetes Tomorrow,s Leaders Scholarship is any indication, the future ... today online at www.diabetesscholars.org by the Diabetes ... stand in the way of academic and community service ... scholarship program since 2012, and continues to advocate for ...
Breaking Medicine Technology: